02487.HK
Cutia Therapeutics
HKSE · Healthcare · Biotechnology · CN
HKD 1.20
−11.76%Margins
Gross margin
53.6%
EBITDA margin
-65.1%
EBIT margin
-72.9%
Net margin
-84.6%
FCF margin
-36.9%
-39.6%
Return on equity
-26.2%
Return on assets
-24.6%
Return on invested capital
0.28x
Asset turnover
-HKD 139.8M
Cash from operations
HKD 2.01
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026